Oliver Stauffer

Oct 3, 2023 | pharmaceuticalonline.com | Oliver Stauffer

Article | October 3, 2023 By Oliver Stauffer When selecting a contract development and manufacturing organization (CDMO), prospective clients prioritize quality assurance, as rigorous quality control procedures play a major role in safeguarding a product on its journey to the patient.

Oct 3, 2023 | meddeviceonline.com | Oliver Stauffer

Get the latest industry news and expert insights delivered straight to your inbox! Article | October 3, 2023 By Oliver Stauffer When selecting a contract development and manufacturing organization (CDMO), prospective clients prioritize quality assurance, as rigorous quality control procedures play a major role in safeguarding a product on its journey to the patient.

Aug 8, 2023 | pharmaceuticalonline.com | Trent Hoffman |Oliver Stauffer |James Fell |Barbara Schulz

By Jonathan B. (J.B.) Fitzgerald, Ph.D., and Trent L. Hoffman Snell & Wilmer attorneys discuss the recent SCOTUS decision to uphold the Federal Circuit's holding that Amgen’s patent claims for functionally claimed antibodies were invalid for failing to meet the enablement requirement. The attorneys share what this means for the industry going forward.

May 25, 2023 | pharmaceuticalonline.com | Victoria Meyer |Joe Hoff |Oliver Stauffer |Grant Merrill

A conversation with Vanessa Figueroa, Rebecca Brewer, and Greg Gibb, Quality Executive Partners In the first of this two-part series, microbiology and contamination control specialists Vanessa Figueroa, Rebecca Brewer, and Greg Gibb, Ph.D., discuss best practices in developing contamination control strategies through the lens of the newly formalized provisions in the EU GMP Annex I, .